| Literature DB >> 28486563 |
Tamara Hoppenbrouwers1,2, Anouchska S A Autar2,3, Andi R Sultan4, Tsion E Abraham5, Wiggert A van Cappellen5, Adriaan B Houtsmuller5, Willem J B van Wamel4, Heleen M M van Beusekom3, Johan W van Neck1, Moniek P M de Maat2.
Abstract
BACKGROUND: Multiple inducers of in vitro Neutrophil Extracellular Trap (NET) formation (NETosis) have been described. Since there is much variation in study design and results, our aim was to create a systematic review of NETosis inducers and perform a standardized in vitro study of NETosis inducers important in (cardiac) wound healing.Entities:
Mesh:
Year: 2017 PMID: 28486563 PMCID: PMC5423591 DOI: 10.1371/journal.pone.0176472
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1PRISM chart of the systematic literature review.
Overview of in-literature described in vitro NETs inducers.
MOI: Multiplicity Of Infection (number of bacteria to number of cells). CFU: Colony Forming Units.
| Inducer | Concentration | Induction time | NETosis | Reference |
|---|---|---|---|---|
| PMA | 4–50 nM (3–30.8 ng/ml) | 10 min-16h | Yes | [ |
| 60–100 nM (37–62 ng/ml) | 30 min-16h | Yes | [ | |
| 120–1620 nM (74–1000 ng/ml) | 10 min-4h | Yes | [ | |
| 100000 nM (6168 ng/ml) | 10 min-24h | Yes | [ | |
| H2O2 | 0.1 μM | 3h | No | [ |
| 100–1000 μM | 4h | Yes | [ | |
| 4000 μM | 200 min | Apoptosis | [ | |
| 10000 μM | 200 min | Necrosis | [ | |
| 10000 μM | 4-5h | Yes | [ | |
| 0.03% | 3h | Yes | [ | |
| IL-8 | 1–250 ng/ml | 10 min-5h | Yes | [ |
| 10 ng/ml | 3h | Little | [ | |
| 100–800 ng/ml | 4-18h | No | [ | |
| IL-1β | 10 ng/ml | 6h | Little | [ |
| 50 ng/ml | 2h | Yes | [ | |
| TNF-α | 1 ng/ml | 6h | Little | [ |
| 7–20 ng/ml | 30 min-5h | Yes | [ | |
| 100 ng/ml | 2h | Yes | [ | |
| 100 ng/ml | 4h | No | [ | |
| Platelets | 5x107 /ml | No | [ | |
| 2x105 – 5x105 | 1h | No | [ | |
| Activated platelets | 2x105 – 5x105 (+ 50 μM TRAP) | 1h | Yes | [ |
| 5x105 (+ 1.3 μg/mL collagen) | 2h | Yes | [ | |
| 1:400 (+ 0.01 U/mL Thrombin) | 4h | Yes | [ | |
| 25–100 ml (+ 5 μmol/L PGE1) | 20 min | Yes | [ | |
| 25–100 ml (+ 25 μmol/l TRAP-6) | 20 min | Yes | [ | |
| 25–100 ml (+ 5 μmol/l ADP) | 20 min | Yes | [ | |
| 25–100 ml (+ 1 μg/ml collagen) | 20 min | Yes | [ | |
| 25–100 ml (+ 0.05 IU/mlrecombinant thrombin) | 20 min | Yes | [ | |
| (+CoCr) | Yes | [ | ||
| A23187 | 0.2–25 μM | 20 min-4h | Yes | [ |
| 1 μM | 1h | No | [ | |
| 100 μM | 1-4h | Little | [ | |
| Ionomycin | 0.9–7 μM | 30 min-4h | Yes | [ |
| 100 μM | 1-4h | Little | [ | |
| MSU crystals | 100–200 μg/ml | 3-5h | Yes | [ |
| 1000 μg/ml | 2h | Yes | [ | |
| Yes | [ | |||
| 20 pg/cell | 2h | Yes | [ | |
| Glucose Oxidase | 100 mU/ml | 1-4h | Yes | [ |
| Glucose | 5.5–10 nM | 2h | No | [ |
| 20–30 nM | 2h | Yes | [ | |
| 5000000 nM | 3h | No | [ | |
| 25000000 nM | 3h | Yes | [ | |
| LPS | 0.1 ng/ml | 1h | Yes | [ |
| 0.1–10 μg/ml | 15 min-18h | Yes | [ | |
| 0.1–25 μg/ml | 2,5-3h | Little | [ | |
| 0.3–5 μg/ml | 15 min | No | [ | |
| 50 μg/ml | 30–90 min | Yes | [ | |
| No | [ | |||
| 10 mg/L | 30 min | Yes | [ | |
| 30 min | Yes | [ | ||
| LPS + Glucose | 2 μg/ml + 30000000 nM | 3h | Little | [ |
| 2.5–25 μg/ml | 2,5h | Yes | [ | |
| LPS + Platelets | 1–5 μg/ml + 5x107-2.4x108 /ml | 30 min + | Yes | [ |
| 25–100 ml + | 20 min | Yes | [ | |
| β-glucan | 200 μg/ml | 15–240 min | Yes | [ |
| 1000 μg/ml | 1h | Yes | [ | |
| 0.03–50 MOI | 30 min-24h | Yes | [ | |
| 6x106/ml | 1h | Yes | [ | |
| 25 μl OD 0.5 | 3h | Yes | [ | |
| 10 MOI | 10 min-24h | Yes | [ | |
| 2x107/ml | 4h | Yes | [ | |
| 4h | No | [ | ||
| 3–50 MOI | 10 min-24h | Yes | [ | |
| 100 MOI | 1-4h | Yes | [ | |
| 106–107 CFU | 5min-1h | Yes | [ | |
| 2000 CFU | 1-8h | Yes | [ | |
| 1–50 MOI | 5h | Some | [ | |
| 10–100 MOI | 10 min-24h | Yes | [ | |
| 8h | Yes | [ | ||
| 6x106/ml | 1h | Yes | [ | |
| 750 CFU / 50 μl | 2h | Yes | [ | |
| 0.2–2000 MOI | 40–180 min | Yes | [ | |
| 106 conidia | 3h | Yes | [ | |
| 0.5 MOI | 90 min | Little | [ | |
| 2 MOI | 15 min | Yes | [ | |
| 2 MOI | 4h | No | [ | |
| 5 MOI | 3h | No | [ | |
| 10 MOI | 3h | Little | [ | |
| 10 MOI | 2h | Yes | [ | |
| 0.2–4.2 MOI | 5-min–4h | Yes | [ | |
| 30 min | Yes | [ | ||
| 10 MOI | 4h | Yes | [ | |
| 10–1000 MOI | 1-4h | No | [ | |
Concentrations of the potential NETosis inducers in the experiments.
| NETosis inducer and final concentrations |
|---|
| PMA (Sigma Aldrich, Saint Louis, Missouri, USA) |
| • 50 ng/ml |
| Platelets (isolated from EDTA blood) |
| • 5x107 /ml |
| Supernatant of activated platelets (isolated from EDTA blood) |
| • 5x107 /ml |
| D-Glucose (Amresco) |
| • 25 μM |
| Ionomycin (Sigma Aldrich) |
| • 3 μg/ml |
| LPS (Sigma Aldrich): source |
| • 10 ng/ml |
| • 10 ng/ml |
| • 10 ng/ml |
| Platelets + LPS ( |
| • 5x107 /ml + 5 μg/ml |
| Activated platelets supernatant + LPS ( |
| 5x107 /ml + 5 μg/ml |
| Living bacteria |
| • 108/ml (±10:1) |
| • 108/ml (±10:1) |
| Dead bacteria |
| • 1010/ml (±1000:1) |
| • 1010/ml (±1000:1) |
Percentage of neutrophils that underwent NETosis.
% NETosis per time point (hr) is given as mean (SEM). P-value of repeated measures ANOVA with Bonferroni post-hoc test results per NETosis inducer versus unstimulated neutrophils.
| n | Time (hr) | p-value | ||||
|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | |||
| 5 | 1.94 (0.43) | 3.8 (1.35) | 3.68 (1.08) | 4.10 (1.34) | n.s. | |
| 7 | 3.89 (0.91) | 7.81(1.64) | 31.94 (6.17) | 61.52 (9.34) | <0.001 | |
| 7 | 2.98 (1.58) | 2.62 (1.26) | 2.90 (1.08) | 3.98 (1.69) | n.s. | |
| 3 | 4.71(1.06) | 4.92 (1.90) | 6.40 (1.98) | 6.58 (1.96) | n.s. | |
| 5 | 2.53 (0.71) | 2.80 (1.12) | 1.12 (0.89) | 1.16 (0.92) | n.s. | |
| 7 | 2.00 (0.60) | 3.24 (1.15) | 1.45 (0.61) | 1.27 (0.47) | n.s. | |
| 7 | 2.84 (1.12) | 4.48 (1.19) | 5.68 (2.31) | 5.94 (2.45) | n.s. | |
| 7 | 2.60 (0.79) | 3.57 (0.72) | 2.43 (1.09) | 3.09 (0.98) | n.s. | |
| 7 | 2.35 (0.77) | 2.75 (1.34) | 2.65 (0.93) | 3.77 (1.09) | n.s. | |
| 7 | 2.87 (1.10) | 6.86 (1.84) | 7.01 (2.88) | 7.88 (3.56) | n.s. | |
Fig 2NETosis induction for the different inducers.
NETosis was defined as the ratio between the number of Hoechst and PI positive cells. PMA induced NETosis when compared to unstimulated neutrophils, p<0.001 repeated measures ANOVA post-hoc Bonferroni (*) (none n = 5, PMA n = 7, LPS n = 7, glucose n = 5). Error Bars +/- SEM.
Fig 3NETs formed by S. aureus and E. coli 20 minutes after stimulation for one hour.
DNA (Hoechst, blue, 405) and Extracelullar DNA (PI, red, 561) were stained.
Fig 4NETosis per inducer comparing the effect of platelets and the effect of activated platelets supernatant (n = 5, n = 7 respectively).
NETosis was defined as the ratio between Hoechst and PI positive cells. Neutrophils stimulated by platelets were compared against neutrophils stimulated by LPS, platelets + LPS, activated platelets, activated platelets + LPS, activated platelets supernatant, activated platelets supernatant + LPS using repeated measures ANOVA post-hoc Bonferroni (*). No significant differences were found (p>0.05 all). Error Bars +/- SEM.
Fig 5The effect of Ionomycin compared to PMA.
(A) Time lapse images of PMA and Ionomycin at different time frames. The arrows indicate the decondensation of the nuclei before (Hoechst, 405) and after (PI, 561) DNA extrusion. (B) The amount of Hoechst and PI positive cells in PMA and Ionomycin stimulated cells and unstimulated cells, show the difference in the process of NETosis. In the PMA stimulated cells, the number of Hoechst positive cells go down as the PI positive cells (NETosis) go up. In the Ionomycin stimulated cells, the number of PI positive cells go up very rapidly, but the Hoechst positive cells remain similar. In unstimulated cells, the intensity of Hoechst staining remains high and no PI staining was detected.